HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yin-Xia Chen Selected Research

Acute Monocytic Leukemia (Acute Monoblastic Leukemia)

10/2019[Effects of Transcription Factor MZF-1 on Transcriptive Regulation of Acute Monocytic Leukemia-related Gene MLAA-34].
6/2019[Cloning of New Antigen Gene MLAA-34 Promoter and Identification of Core Region in Acute Monocytic Leukemia].
2/2018[Detection of Novel Antigen MLAA-34 Gene Mutation in Acute Monocytic Leukemia and Its Correlation with Efficacy].
2/2013The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells.
2/2010[Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].
10/2009[Expression of genes psma6 and slc25a4 in patients with acute monocytic leukemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yin-Xia Chen Research Topics

Disease

6Acute Monocytic Leukemia (Acute Monoblastic Leukemia)
10/2019 - 10/2009
5Leukemia
04/2016 - 06/2007
4Multiple Myeloma
12/2018 - 04/2006
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2015 - 03/2008
3Neoplasms (Cancer)
12/2018 - 04/2006
3Non-Hodgkin Lymphoma (Lymphosarcoma)
04/2016 - 01/2014
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2016 - 10/2008
2Thrombocytopenia (Thrombopenia)
12/2018 - 04/2015
1Leukopenia
12/2018
1Lymphoma (Lymphomas)
08/2016
1Hypersensitivity (Allergy)
04/2016
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
04/2016
1Drug-Related Side Effects and Adverse Reactions
04/2016
1Aplastic Anemia (Anemia, Hypoplastic)
03/2016
1Hemorrhage
04/2015
1Infections
04/2015
1Anemia
04/2015
1Carcinogenesis
02/2013
1Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
04/2009
1Cytopenia
10/2005
1Refractory Anemia
10/2005

Drug/Important Bio-Agent (IBA)

6Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2016 - 03/2008
6Cytarabine (Cytosar-U)FDA LinkGeneric
01/2016 - 03/2008
5AntigensIBA
06/2019 - 04/2006
5HomoharringtonineIBA
01/2016 - 03/2008
2Therapeutic UsesIBA
03/2016 - 06/2007
2Proteins (Proteins, Gene)FDA Link
02/2013 - 04/2006
2Thalidomide (Thalomid)FDA Link
12/2008 - 12/2006
1Transcription Factors (Transcription Factor)IBA
10/2019
1B-Cell Maturation AntigenIBA
12/2018
1Chimeric Antigen ReceptorsIBA
12/2018
1EpitopesIBA
12/2018
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2018
1Aligeron (AS 2)IBA
04/2016
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
03/2016
1Interleukin-10 (Interleukin 10)IBA
01/2014
1CalciumIBA
02/2013
1ChemokinesIBA
02/2013
1Messenger RNA (mRNA)IBA
10/2009
1Indicators and Reagents (Reagents)IBA
10/2009
1Inosine Triphosphate (ITP)IBA
04/2009
1AntibodiesIBA
04/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2008
1Tryptophan (L-Tryptophan)FDA Link
06/2007
1CytokinesIBA
12/2006
1Translationally-Controlled 1 Tumor ProteinIBA
04/2006
1Complementary DNA (cDNA)IBA
04/2006
1Hemoglobins (Hemoglobin)IBA
10/2005
1Tretinoin (Retinoic Acid)FDA LinkGeneric
10/2005
1AndrogensIBA
10/2005

Therapy/Procedure

7Drug Therapy (Chemotherapy)
08/2016 - 03/2008
3Therapeutics
12/2018 - 10/2009
1Immunotherapy
10/2009
1Combination Drug Therapy (Combination Chemotherapy)
03/2008